Vaccination with clumping factor A and fibronectin binding protein A to prevent Staphylococcus aureus infection of an aortic patch in mice.

Staphylococcus aureus is a leading cause of ventricular assist device-related infections. This study evaluated the protective effect against S. aureus infection of active and passive immunization that targeted 3 proteins involved in bacterial attachment to a murine intra-aortic polyurethane patch. Active immunization of mice with a combination of the A domains of clumping factor A (ClfA), fibronectin-binding protein A (FnBPA) and fibronectin-binding protein B or passive immunization with monoclonal antibodies against ClfA and FnBPA resulted in a higher level of protection than that obtained by vaccination with either protein or antibody alone. The combination of antibodies or protein antigens appears to provide enhanced protection against prosthetic-device infection.

[1]  O. Schneewind,et al.  Vaccine assembly from surface proteins of Staphylococcus aureus , 2006, Proceedings of the National Academy of Sciences.

[2]  F. Lowy,et al.  Ventricular assist device-related infections. , 2006, The Lancet. Infectious diseases.

[3]  C. Arrecubieta,et al.  The role of Staphylococcus aureus adhesins in the pathogenesis of ventricular assist device-related infections. , 2006, The Journal of infectious diseases.

[4]  S. Black,et al.  Prospects for active and passive immunization against Staphylococcus aureus. , 2006, The Pediatric infectious disease journal.

[5]  Patrice François,et al.  Fibrinogen and fibronectin binding cooperate for valve infection and invasion in Staphylococcus aureus experimental endocarditis , 2005, The Journal of experimental medicine.

[6]  G. Couper,et al.  Infection in permanent circulatory support: experience from the REMATCH trial. , 2004, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[7]  F. Roche,et al.  The N-terminal A Domain of Fibronectin-binding Proteins A and B Promotes Adhesion of Staphylococcus aureus to Elastin* , 2004, Journal of Biological Chemistry.

[8]  T. Foster,et al.  Protection against experimental Staphylococcus aureus arthritis by vaccination with clumping factor A, a novel virulence determinant. , 2001, The Journal of infectious diseases.

[9]  M C Oz,et al.  Time-dependent cellular population of textured-surface left ventricular assist devices contributes to the development of a biphasic systemic procoagulant response. , 1999, The Journal of thoracic and cardiovascular surgery.

[10]  T. Foster,et al.  The Fibrinogen-binding MSCRAMM (Clumping Factor) ofStaphylococcus aureus Has a Ca2+-dependent Inhibitory Site* , 1998, The Journal of Biological Chemistry.

[11]  P. François,et al.  Role of Staphylococcus aureus coagulase and clumping factor in pathogenesis of experimental endocarditis , 1995, Infection and immunity.

[12]  A. Heimdahl,et al.  Immunization with fibronectin binding protein from Staphylococcus aureus protects against experimental endocarditis in rats. , 1993, Microbial pathogenesis.

[13]  A. Tarkowski,et al.  Outbreak of spontaneous staphylococcal arthritis and osteitis in mice. , 1990, Arthritis and rheumatism.

[14]  M. Lindberg,et al.  Vaccination against Staphylococcus aureus mastitis: immunological response of mice vaccinated with fibronectin-binding protein (FnBP-A) to challenge with S. aureus. , 1994, Vaccine.

[15]  M. Höök,et al.  MSCRAMM-mediated adherence of microorganisms to host tissues. , 1994, Annual review of microbiology.